Business Description
IXICO PLC
ISIN : GB00BFXR4C20
Total Employee Number:
79Description
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.45 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.6 | |||||
3-Year FCF Growth Rate | -9.5 | |||||
3-Year Book Growth Rate | -21.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.83 | |||||
Quick Ratio | 2.83 | |||||
Cash Ratio | 0.93 | |||||
Days Sales Outstanding | 86.98 | |||||
Days Payable | 111.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.4 | |||||
Shareholder Yield % | 1.59 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50.76 | |||||
Operating Margin % | -38.87 | |||||
Net Margin % | -24.98 | |||||
EBITDA Margin % | -36.7 | |||||
FCF Margin % | -44.74 | |||||
OCF Margin % | -29.46 | |||||
ROE % | -15.69 | |||||
ROA % | -13.33 | |||||
ROIC % | -17.93 | |||||
3-Year ROIIC % | -165.88 | |||||
ROC (Joel Greenblatt) % | -243.98 | |||||
ROCE % | -26.54 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.07 | |||||
PB Ratio | 0.73 | |||||
Price-to-Tangible-Book | 2.11 | |||||
EV-to-EBIT | -5.56 | |||||
EV-to-Forward-EBIT | 32.47 | |||||
EV-to-EBITDA | -6.51 | |||||
EV-to-Revenue | 2.39 | |||||
EV-to-Forward-Revenue | 0.41 | |||||
EV-to-FCF | -5.34 | |||||
Price-to-GF-Value | 1 | |||||
| Price-to-Net-Current-Asset-Value | 2.82 | |||||
Earnings Yield (Greenblatt) % | -17.99 | |||||
FCF Yield % | -17.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PHYOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IXICO PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.76 | ||
| EPS (TTM) ($) | -0.026 | ||
| Beta | 61.068 | ||
| 3-Year Sharpe Ratio | 0.57 | ||
| 3-Year Sortino Ratio | 62.96 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.07 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.07 - 0.07 | ||
| Shares Outstanding (Mil) | 218.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IXICO PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IXICO PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2026-12-09 16:30 | In 166 days | ||
| Annual report for 2026 | 2026-12-09 | In 165 days | ||
| Fourth quarter earnings results for 2026 | 2026-12-09 | In 165 days | ||
| Second quarter earnings conference call for 2026 | 2026-05-19 15:30 | 0.07 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-05-19 | 0.07 (+0.00%) | ||
| General meeting for 2026 | 2026-01-23 10:30 | 0.07 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-12-09 16:30 | 0.07 (+0.00%) | ||
| Annual report for 2025 | 2025-12-09 | 0.07 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2025-12-09 | 0.07 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-05-20 16:30 | 0.07 (+0.00%) |
Show
Entries
IXICO PLC Frequently Asked Questions
What is IXICO PLC(PHYOF)'s stock price today?
The current price of PHYOF is $0.07. The 52 week high of PHYOF is $0.07 and 52 week low is $0.07.
When is next earnings date of IXICO PLC(PHYOF)?
The next earnings date of IXICO PLC(PHYOF) is 2026-12-09 Est..
Does IXICO PLC(PHYOF) pay dividends? If so, how much?
IXICO PLC(PHYOF) does not pay dividend.
Guru Commentaries on OTCPK:PHYOF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on IXICO PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers